Clinical trial
PSG and Neuroendocrine Hormones in Subjective Cognitive Impaired Patients With Transformed Migraine
NCT04413110 is registered in ClinicalTrials.gov with Mansoura University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- PSG and Neuroendocrine Hormones in Subjective Cognitive Impaired Patients With Transformed Migraine
- Lead sponsor
- Mansoura University Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 1, 2019
- Completion date
- April 1, 2020
- Enrollment
- 161 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
migraine